University of New Mexico Cancer Center Support Grant

新墨西哥大学癌症中心支持补助金

基本信息

项目摘要

 DESCRIPTION (provided by applicant): The Cancer Control (CaC) Research Program is a newly restructured transdisciplinary program that serves as the hub for cancer control and population science research within the University of New Mexico Cancer Center (UNMCC) and the State of New Mexico (NM), our catchment area. The Program's overall goal is to reduce cancer incidence, morbidity, and mortality, particularly in the unique multiethnic and underserved populations of NM. Disparities research is a cross-cutting theme that fosters scientific focus and synergy across the research areas. Through vigorous strategic program planning and evaluation, recruitment of 9 new investigators to enhance expertise in molecular epidemiology and behavioral/community intervention, and guidance of the UNMCC External Advisory Committee, the CaC Program is now focused on three areas of cancer research: 1) Risk Prediction and Risk Reduction; 2) Screening; and 3) Post-Diagnosis Outcomes and Survivorship. Unique scientific strengths include research addressing disparities (geographic, race/ethnic, socioeconomic, medically underserved), particularly in etiologic, outcome, and intervention studies in Hispanics. By drawing on established and new partnerships, the Program is also building research that addresses American Indian cancer disparities and priorities identified by NM Tribes, Pueblos, and Indian Nations. Major scientific accomplishments in Risk Prediction and Risk Reduction include the identification of social, lifestyle, and genetic factors associated with lung cancer risk; gene-environment interactions in melanoma risk; and development and dissemination of a novel telehealth strategy for the prevention of hepatocellular cancer. In Screening, members have developed a statewide surveillance program of screening and diagnosis for cervical pre-cancer and cancer that informs real- world cervical cancer prevention through human papilloma virus (HPV) vaccination, screening practice and outcomes. Members have also identified barriers to use of early detection tests in colorectal cancer and have developed strategies to overcome these barriers to improve screening in underserved populations. In Post- Diagnosis Outcomes and Survivorship, members have identified factors that contribute to disparities in post- treatment outcomes and survivorship in endometrial and breast cancer and are developing interventions. Led by Linda Cook, Ph.D. and Anita Kinney, Ph.D., RN, the CaC Program is comprised of 28 members (19 full and 9 associate) from 7 UNM schools and departments, the Lovelace Respiratory Institute, and the Indian Health Service Unit of the Centers for Disease Control whose work is supported by $19,276,863 million in annual direct cost funding, of which $15,429,911 million is peer-reviewed and $3,137,820 million is from NCI as of 9/1/2014. The discoveries made in this Program have resulted 294 publications, of which 19% are intra-programmatic collaborations and 16% are inter-programmatic collaborations; with a total UNMCC and external collaborative publication level of 30% and 80%, respectively.
 描述(由适用提供):癌症控制(CAC)研究计划是一项新修复的跨学科计划,在新墨西哥大学癌症中心(UNMCC)和新墨西哥州(NM)(NM)(我们的集水区)中充当癌症控制和人口科学研究的枢纽。该计划的总体目标是降低癌症的发病率,发病率和死亡率,特别是在NM的独特多种族和服务不足的人群中。差异研究是一个横切主题,它促进了整个研究领域的科学重点和协同作用。通过有力的战略计划计划和评估,招募9名新研究人员,以增强分子流行病学和行为/社区干预方面的专业知识,以及UNMCC外部咨询委员会的指导,CAC计划现在侧重于癌症研究的三个领域:1)风险预测和风险降低; 2)筛选; 3)诊断后的结果和生存。独特的科学优势包括解决差异的研究(地理,种族/种族,社会经济,医疗服务不足),尤其是在西班牙裔的病因,结果和干预研究中。通过利用已建立和新的合作伙伴关系,该计划还正在建立研究,该研究涉及NM部落,普韦布洛斯和印度国家确定的美洲印第安癌症分配和优先事项。风险预测和降低风险的主要科学成就包括确定与肺癌风险相关的社会,生活方式和遗传因素;黑色素瘤风险中的基因环境相互作用;以及针对预防肝癌的新型远程医疗策略的发展和传播。在筛查中,成员已经制定了一项全州筛查和诊断症的监视计划,用于宫颈前癌和癌症,该计划通过人类乳头状瘤病毒(HPV)疫苗,筛查实践和结果来告知现实世界中的宫颈癌预防。成员还确定了在有色癌症中使用早期检测测试的障碍,并制定了克服这些障碍以改善服务不足人群筛查的策略。在诊断后的结局和生存期间,成员已经确定了导致治疗后结果和子宫内膜和乳腺癌生存差异的因素,并且正在发展干预措施。由Linda Cook博士领导。和RN的Anita Kinney博士,CAC计划由28名成员(19名和9个副部门)组成,来自7个UNM学校和部门,Lovelace呼吸研究所和疾病控制中心的印度卫生服务中心,其工作由每年的导演成本为19,276300万美元,其中包括19,276,8.63亿美元,其中包括15,911亿美元的pe。截至2014年9月1日,NCI $ 3,137,8.2亿美元。该计划中提出的发现产生了294个出版物,其中19%是策略内合作,有16%是程序间合作。总共汇率和外部协作出版物级别分别为30%和80%。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHERYL LYNN WILLMAN其他文献

CHERYL LYNN WILLMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHERYL LYNN WILLMAN', 18)}}的其他基金

Mayo Comprehensive Cancer Center Grant (MICEO Supp) - Impact of Multi-Channel Communication Campaigns on Cancer Prevention, Control and Survivorship (CaPCaS) in Black, Hispanic, and Rural Populations
梅奥综合癌症中心拨款 (MICEO Supp) - 多渠道沟通活动对黑人、西班牙裔和农村人口癌症预防、控制和生存 (CaPCaS) 的影响
  • 批准号:
    10889628
  • 财政年份:
    2023
  • 资助金额:
    $ 12.35万
  • 项目类别:
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing - Administrative Core
西南部落国家的美洲印第安人参与癌症基因组测序 - 行政核心
  • 批准号:
    10251930
  • 财政年份:
    2020
  • 资助金额:
    $ 12.35万
  • 项目类别:
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing - Administrative Core
西南部落国家的美洲印第安人参与癌症基因组测序 - 行政核心
  • 批准号:
    10700790
  • 财政年份:
    2020
  • 资助金额:
    $ 12.35万
  • 项目类别:
Senior Leadership
高层领导
  • 批准号:
    8723084
  • 财政年份:
    2013
  • 资助金额:
    $ 12.35万
  • 项目类别:
Program Planning and Evaluation
项目规划与评估
  • 批准号:
    8180629
  • 财政年份:
    2010
  • 资助金额:
    $ 12.35万
  • 项目类别:
Developmental Funds
发展基金
  • 批准号:
    8180632
  • 财政年份:
    2010
  • 资助金额:
    $ 12.35万
  • 项目类别:
Cancer Center Research Administration
癌症中心研究管理
  • 批准号:
    8180635
  • 财政年份:
    2010
  • 资助金额:
    $ 12.35万
  • 项目类别:
Senior Leadership
高层领导
  • 批准号:
    8180624
  • 财政年份:
    2010
  • 资助金额:
    $ 12.35万
  • 项目类别:
University of New Mexico Cancer Center Support
新墨西哥大学癌症中心支持
  • 批准号:
    7498738
  • 财政年份:
    2005
  • 资助金额:
    $ 12.35万
  • 项目类别:
PLANNING & EVALUATION
规划
  • 批准号:
    7127346
  • 财政年份:
    2005
  • 资助金额:
    $ 12.35万
  • 项目类别:

相似海外基金

Planning and Evaluation Core
规划与评估核心
  • 批准号:
    10762147
  • 财政年份:
    2023
  • 资助金额:
    $ 12.35万
  • 项目类别:
Planning and Evaluation Core
规划与评估核心
  • 批准号:
    10762276
  • 财政年份:
    2023
  • 资助金额:
    $ 12.35万
  • 项目类别:
Cancer-related cognitive impairment: Real-time evaluation and assessment of long-term impact of treatment on young adult survivors (CRCI REALITY)
癌症相关认知障碍:实时评估和评估治疗对年轻成年幸存者的长期影响(CRCI REALITY)
  • 批准号:
    10427965
  • 财政年份:
    2022
  • 资助金额:
    $ 12.35万
  • 项目类别:
Neurocognitive Impairments Resulting from Adolescent Prescription Opioid Use Disorder: Longitudinal Impact, Neural Mechanisms, and Comorbidities
青少年处方阿片类药物使用障碍导致的神经认知障碍:纵向影响、神经机制和合并症
  • 批准号:
    10481236
  • 财政年份:
    2022
  • 资助金额:
    $ 12.35万
  • 项目类别:
Children's Hospital Los Angeles Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
洛杉矶儿童医院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
  • 批准号:
    10709604
  • 财政年份:
    2022
  • 资助金额:
    $ 12.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了